This is stated in the message of the fund.
“Viscoran İlaç has carried out preparations for the localization of production and plans to start production of Sputnik V within the next few months at several enterprises,” the RDIF said.
It is noted that "within the framework of the agreement with RDIF, Viscoran İlaç also provides support for the formation of partnerships with other local pharmaceutical manufacturers."
"In particular, the process of technological transfer is being finalized with CinnaGen İlaç, negotiations are underway with two other production sites to expand the vaccine production capacity," the fund added.
Sputnik V is currently registered in 61 countries with a total population of over 3 billion people.
Earlier, the presidents of Russia and Egypt, Vladimir Putin and Abdel Fattah el-Sisi discussed the localization of the production of Russian vaccines against coronavirus in the republic.